Target intelligence / Profile preview

Phenolic compound metabolism by gut bacteria

Molecular classification
Other (not a single molecule, receptor, enzyme, or protein family; refers to a metabolic process involving multiple bacterial enzymes and pathways)
01

Overview

Phenolic compound metabolism by gut bacteria refers to the collective set of enzymatic processes carried out primarily in the colon by diverse members of the human intestinal microbiota. These microbes transform dietary polyphenols—plant-derived secondary metabolites with antioxidant and anti-inflammatory properties—into smaller molecules that are more readily absorbed into circulation. The transformation involves various reactions such as hydrolysis, ring fission, reduction, demethylation, decarboxylation, dihydroxylation, and isomerization. Key bacterial genera involved include Bacteroides, Eubacterium, Roseburia, Butyrivibrio (Lachnospiraceae), Ruminococcus, Faecalibacterium prausnitzii for xylan degradation and release/reduction of ferulic acid from plant cell walls; other species like Lactobacillus plantarum IFPL935 or Eggerthella lenta participate in flavan–3–ol conversion into valerolactones[1][2]. This metabolic activity has significant implications for human health because it determines both the availability and biological effects of polyphenols after ingestion. The resulting microbial metabolites have been associated with beneficial outcomes including improved cardiovascular health through inhibition of platelet activation or modulation of insulin signaling; neuroprotection via blood-brain barrier-permeable compounds; anti-cancer activities; modulation of inflammation; prebiotic stimulation favoring beneficial bacterial families like Bifidobacteriaceae/Lactobacillaceae while suppressing pathogens[1][2][3]. However, "Phenolic compound metabolism by gut bacteria" is not itself a single molecular entity or canonical drug target but rather describes an ecological/metabolic function distributed across many taxa within the microbiome using diverse enzymatic machinery. As such it does not fit standard definitions for therapeutic targets like receptors or enzymes. Therefore: • This entry should be flagged as incorrect if used where a discrete molecular target is required. • It represents an important functional axis at the interface between diet/microbiome/host physiology but cannot be mapped onto one gene/protein/receptor/enzyme. • Research continues into identifying key strains/enzymes responsible for specific transformations within this broad category.[4]

Other names
Gut microbial phenolic metabolismMicrobial biotransformation of phenolicsPolyphenol metabolism by gut microbiotaColonic phenolic catabolism
02

Biological functions

Metabolism of dietary polyphenols and phenolicsModulation of host bioavailability and bioactivity of plant-derived compoundsPrebiotic effects on gut microbiota composition[2][5]Generation of bioactive metabolites with systemic effects[1][3]
03

Disease associations

Cancer (protective roles via anti-inflammatory/antioxidant metabolites)[1]Cardiovascular disease (modulation via SCFA and other metabolites)[1]Neurodegenerative disease (neuroprotective metabolite production)[3]Metabolic syndrome/diabetes (improved insulin signaling, reduced symptoms)[1]Inflammation[2][5]
04

Safety considerations

No direct safety concerns specific to targeting this process. However, inter-individual variability in microbial composition can lead to unpredictable metabolite profiles and responses[2].
05

Biomarkers

Metabolites such as ferulic acid derivatives or valerolactones in plasma/urine may serve as indirect biomarkers for the activity of this pathway in research settings[2].

Beyond the preview

Go deeper on Phenolic compound metabolism by gut bacteria.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phenolic compound metabolism by gut bacteria.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call